Export

Spironolactone
Essential medicine status
General description

INN
Spironolactone
Medicine type
Chemical agent
EML status history
First added in 1977 (TRS 615) for Oedema
Added in 1977 (TRS 615) for Ascites
Removed in 1979 (TRS 641) for Oedema
Removed in 1979 (TRS 641) for Ascites
Added in 1982 (TRS 685) for Oedema
Added in 1982 (TRS 685) for Ascites
Added in 2013 (TRS 985) for Heart failure
Therapeutic equivalent for
Recommendations
Section
Medicines used in heart failure
  • Oral > Solid: 25 mg
Indications
Section
Diuretics
  • Oral > Liquid: 10 mg per 5 mL; 25 mg per 5 mL; 5 mg per 5 mL
  • Oral > Solid: 25 mg